237 related articles for article (PubMed ID: 15728730)
1. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects.
Hu Z; Cha SH; van Haasteren G; Wang J; Lane MD
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3972-7. PubMed ID: 15728730
[TBL] [Abstract][Full Text] [Related]
2. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides.
Shimokawa T; Kumar MV; Lane MD
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):66-71. PubMed ID: 11756683
[TBL] [Abstract][Full Text] [Related]
3. Effect of the anorectic fatty acid synthase inhibitor C75 on neuronal activity in the hypothalamus and brainstem.
Gao S; Lane MD
Proc Natl Acad Sci U S A; 2003 May; 100(10):5628-33. PubMed ID: 12724522
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic malonyl-CoA as a mediator of feeding behavior.
Hu Z; Cha SH; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12624-9. PubMed ID: 14532332
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of prolonged food restriction and fasting on hypothalamic malonyl-CoA concentration and expression of orexigenic and anorexigenic neuropeptides genes in rats.
Sucajtys-Szulc E; Turyn J; Goyke E; Korczynska J; Stelmanska E; Slominska E; Smolenski RT; Rutkowski B; Swierczynski J
Neuropeptides; 2010 Feb; 44(1):17-23. PubMed ID: 20004973
[TBL] [Abstract][Full Text] [Related]
7. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
Takahashi KA; Smart JL; Liu H; Cone RD
Endocrinology; 2004 Jan; 145(1):184-93. PubMed ID: 14512433
[TBL] [Abstract][Full Text] [Related]
8. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment.
Kim EK; Miller I; Landree LE; Borisy-Rudin FF; Brown P; Tihan T; Townsend CA; Witters LA; Moran TH; Kuhajda FP; Ronnett GV
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E867-79. PubMed ID: 12376313
[TBL] [Abstract][Full Text] [Related]
9. Effect of centrally administered C75, a fatty acid synthase inhibitor, on gastric emptying and gastrointestinal transit in mice.
Li LF; Lu YY; Xiong W; Liu JY; Chen Q
Eur J Pharmacol; 2008 Oct; 595(1-3):90-4. PubMed ID: 18706411
[TBL] [Abstract][Full Text] [Related]
10. Involvement of stomach ghrelin and hypothalamic neuropeptides in tumor necrosis factor-alpha-induced hypophagia in mice.
Endo M; Masaki T; Seike M; Yoshimatsu H
Regul Pept; 2007 Apr; 140(1-2):94-100. PubMed ID: 17187875
[TBL] [Abstract][Full Text] [Related]
11. Mode of leptin action in chicken hypothalamus.
Dridi S; Swennen Q; Decuypere E; Buyse J
Brain Res; 2005 Jun; 1047(2):214-23. PubMed ID: 15907812
[TBL] [Abstract][Full Text] [Related]
12. Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty.
Lebrethon MC; Aganina A; Fournier M; Gérard A; Parent AS; Bourguignon JP
J Neuroendocrinol; 2007 Mar; 19(3):181-8. PubMed ID: 17280591
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice.
Kumar MV; Shimokawa T; Nagy TR; Lane MD
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1921-5. PubMed ID: 11854492
[TBL] [Abstract][Full Text] [Related]
14. Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents.
Rohrbach KW; Han S; Gan J; O'Tanyi EJ; Zhang H; Chi CL; Taub R; Largent BL; Cheng D
Eur J Pharmacol; 2005 Mar; 511(1):31-41. PubMed ID: 15777777
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptides and the control of food intake in fish.
Volkoff H; Canosa LF; Unniappan S; Cerdá-Reverter JM; Bernier NJ; Kelly SP; Peter RE
Gen Comp Endocrinol; 2005 May; 142(1-2):3-19. PubMed ID: 15862543
[TBL] [Abstract][Full Text] [Related]
16. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
Thupari JN; Kim EK; Moran TH; Ronnett GV; Kuhajda FP
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E97-E104. PubMed ID: 14736702
[TBL] [Abstract][Full Text] [Related]
17. The effect of adrenalectomy on ghrelin secretion and orexigenic action.
Proulx K; Vahl TP; Drazen DL; Woods SC; Seeley RJ
J Neuroendocrinol; 2005 Jul; 17(7):445-51. PubMed ID: 15946162
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid metabolism as a target for obesity treatment.
Ronnett GV; Kim EK; Landree LE; Tu Y
Physiol Behav; 2005 May; 85(1):25-35. PubMed ID: 15878185
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
[TBL] [Abstract][Full Text] [Related]
20. A role for ghrelin in the central regulation of feeding.
Nakazato M; Murakami N; Date Y; Kojima M; Matsuo H; Kangawa K; Matsukura S
Nature; 2001 Jan; 409(6817):194-8. PubMed ID: 11196643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
